Starting a century ago, CSL Behring made a promise to save lives and protect the health of people. Today that same promise has never been stronger. A global leader in the biotherapeutics industry, CSL Behring is passionate about improving the quality of patients' lives and remains committed to the global bleeding disorders community. CSL Behring manufactures and markets a range of recombinant and plasma-derived products for the treatment of hemophilia, von Willebrand Disease and other bleeding disorders.  We are proud to be able to sponsor chapter programs such as Oklahoma’s Annual Meeting.